Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Audus

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Pharmaceutical Sciences|February 25, 2006
Tetrazole compounds: the effect of structure and pH on Caco-2 cell permeabilityAmber M Young, Kenneth L Audus, John Proudfoot, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 7, 2009
Lipopolysaccharide increases the expression of multidrug resistance-associated protein 1 (MRP1) in RAW 264.7 macrophagesPeter S Silverstein, Kenneth L Audus, Nilofer Qureshi, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 23, 2006
Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MSArvind K Chappa, Joshua D Cooper, Kenneth L Audus, et al.
Peptides|October 11, 2012
The permeation of dynorphin A 1-6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeabilityCourtney D Kuhnline Sloan, Kenneth L Audus, Jane V Aldrich, et al.
Journal of Molecular Neuroscience : MN|September 23, 2003
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumorsAntonie Rice, Mary L Michaelis, Gunda Georg, et al.
Journal of Pharmaceutical Sciences|September 5, 2002
A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitroErin D Hugger, Barbara L Novak, Philip S Burton, et al.
International Journal of Pharmaceutics|March 19, 2002
Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrierChadarat Ampasavate, Gurudatt A Chandorkar, David G Vande Velde, et al.
Journal of Medicinal Chemistry|February 4, 2005
Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situAntonie Rice, Yanbin Liu, Mary Lou Michaelis, et al.
Methods in Molecular Medicine|March 4, 2006
In vitro models for studying trophoblast transcellular transportClaudia J Bode, Hong Jin, Erik Rytting, et al.
Annual Review of Analytical Chemistry (Palo Alto, Calif.)|June 20, 2012
Analytical and biological methods for probing the blood-brain barrierCourtney D Kuhnline Sloan, Pradyot Nandi, Thomas H Linz, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Pharmaceutical Sciences|February 25, 2006
Tetrazole compounds: the effect of structure and pH on Caco-2 cell permeabilityAmber M Young, Kenneth L Audus, John Proudfoot, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 7, 2009
Lipopolysaccharide increases the expression of multidrug resistance-associated protein 1 (MRP1) in RAW 264.7 macrophagesPeter S Silverstein, Kenneth L Audus, Nilofer Qureshi, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 23, 2006
Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MSArvind K Chappa, Joshua D Cooper, Kenneth L Audus, et al.
Peptides|October 11, 2012
The permeation of dynorphin A 1-6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeabilityCourtney D Kuhnline Sloan, Kenneth L Audus, Jane V Aldrich, et al.
Journal of Molecular Neuroscience : MN|September 23, 2003
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumorsAntonie Rice, Mary L Michaelis, Gunda Georg, et al.
Journal of Pharmaceutical Sciences|September 5, 2002
A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitroErin D Hugger, Barbara L Novak, Philip S Burton, et al.
International Journal of Pharmaceutics|March 19, 2002
Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrierChadarat Ampasavate, Gurudatt A Chandorkar, David G Vande Velde, et al.
Journal of Medicinal Chemistry|February 4, 2005
Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situAntonie Rice, Yanbin Liu, Mary Lou Michaelis, et al.
Methods in Molecular Medicine|March 4, 2006
In vitro models for studying trophoblast transcellular transportClaudia J Bode, Hong Jin, Erik Rytting, et al.
Annual Review of Analytical Chemistry (Palo Alto, Calif.)|June 20, 2012
Analytical and biological methods for probing the blood-brain barrierCourtney D Kuhnline Sloan, Pradyot Nandi, Thomas H Linz, et al.
Pageof 7